Table 4_MicroRNAs and suicidality: a systematic review and bioinformatic evaluation.xlsx

IntroductionSuicide is a leading global cause of mortality (~800,000 deaths annually) driven by complex biological and environmental determinants; although microRNAs (miRNAs) regulate gene expression implicated in psychiatric disorders, their contributions to suicidality-related phenotypes remain incompletely defined.
MethodsWe searched Web of Science, PubMed, Scopus, Embase, and Ovid through July 14, 2025, for human case–control studies comparing individuals with suicidality-related phenotypes to non-suicidal controls. Risk of bias was assessed with the Newcastle–Ottawa Scale. Differentially expressed miRNAs were compiled and analyzed to identify brain-specific gene targets, followed by pathway and disease enrichment.
ResultsOf 1,437 records screened, 13 studies met inclusion criteria, encompassing 285 suicidal participants and 291 controls. Across studies, 43 unique miRNAs showed significant differential expression between cases and controls. Three miRNAs—miR-30a, miR-30e, and miR-218—were consistently dysregulated across brain samples from individuals who died by suicide. Bioinformatic analyses indicated that these miRNAs converge on brain-expressed targets and processes relevant to psychiatric biology. Enrichment highlighted pathways involved in transcriptional regulation, forkhead box O (FoxO) signaling, Ras-associated protein-1 (Rap1) signaling, long-term depression, and dopaminergic synapse function.
ConclusionmiR-30a, miR-30e, and miR-218 emerge as recurrently altered miRNAs in suicide and may serve as mechanistic mediators and candidate biomarkers. Mapping their brain-specific targets and enriched pathways suggests actionable avenues for risk stratification and therapeutic development.
Systematic Review Registrationhttps://www.crd.york.ac.uk/prospero/, identifier PROSPERO CRD42024582398.